Literature DB >> 19158279

Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta.

Yoshihide Asano1, Maria Trojanowska.   

Abstract

Previous studies have shown that transforming growth factor beta (TGF-beta)-induced collagen gene expression involves acetylation-dependent dissociation from the human alpha2(I) collagen (COL1A2) promoter of the transcriptional repressor Fli1. The goal of this study was to elucidate the regulatory steps preceding the acetylation of Fli1. We first showed that TGF-beta induces Fli1 phosphorylation on a threonine residue(s). The major phosphorylation site was localized to threonine 312 located in the DNA binding domain of Fli1. Using several independent approaches, we demonstrated that Fli1 is directly phosphorylated by protein kinase C delta (PKC delta). Additional experiments showed that in response to TGF-beta, PKC delta is recruited to the collagen promoter to phosphorylate Fli1 and that this step is a prerequisite for the subsequent interaction of Fli1 with p300/CREB-binding protein-associated factor (PCAF) and an acetylation event. The phosphorylation of endogenous Fli1 preceded its acetylation in response to TGF-beta stimulation, and the blockade of PKC delta abrogated both the phosphorylation and acetylation of Fli1 in dermal fibroblasts. Promoter studies showed that a phosphorylation-deficient mutant of Fli1 exhibited an increased inhibitory effect on the COL1A2 gene, which could not be reversed by the forced expression of PCAF or PKC delta. These data strongly suggest that the phosphorylation-acetylation cascade triggered by PKC delta represents the primary mechanism whereby TGF-beta regulates the transcriptional activity of Fli1 in the context of the collagen promoter.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158279      PMCID: PMC2655609          DOI: 10.1128/MCB.01320-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway.

Authors:  J Czuwara-Ladykowska; F Shirasaki; P Jackers; D K Watson; M Trojanowska
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

2.  Transforming growth factor-beta 1 regulates Kir2.3 inward rectifier K+ channels via phospholipase C and protein kinase C-delta in reactive astrocytes from adult rat brain.

Authors:  Pablo R Perillan; Mingkui Chen; Eric A Potts; J Marc Simard
Journal:  J Biol Chem       Date:  2001-11-16       Impact factor: 5.157

3.  Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.

Authors:  Madoka Sato; Daniel Shegogue; Elizabeth A Gore; Edwin A Smith; Paul J McDermott; Maria Trojanowska
Journal:  J Invest Dermatol       Date:  2002-04       Impact factor: 8.551

4.  TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression.

Authors:  T Hayashida; A C Poncelet; S C Hubchak; H W Schnaper
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

5.  Protein kinase CK2 mediates TGF-beta1-stimulated type IV collagen gene transcription and its reversal by estradiol.

Authors:  M Zdunek; S Silbiger; J Lei; J Neugarten
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

6.  Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts.

Authors:  S A Jimenez; S Gaidarova; B Saitta; N Sandorfi; D J Herrich; J C Rosenbloom; U Kucich; W R Abrams; J Rosenbloom
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

7.  Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia.

Authors:  A Hart; F Melet; P Grossfeld; K Chien; C Jones; A Tunnacliffe; R Favier; A Bernstein
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

8.  Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor.

Authors:  D D Spyropoulos; P N Pharr; K R Lavenburg; P Jackers; T S Papas; M Ogawa; D K Watson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

9.  Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK.

Authors:  C D Douillet; V Velarde; J T Christopher; R K Mayfield; M E Trojanowska; A A Jaffa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

10.  Characterization of a GC-rich region containing Sp1 binding site(s) as a constitutive responsive element of the alpha 2(I) collagen gene in human fibroblasts.

Authors:  T Tamaki; K Ohnishi; C Hartl; E C LeRoy; M Trojanowska
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

View more
  30 in total

Review 1.  The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.

Authors:  Yoshihide Asano; Andreea M Bujor; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2010-07-03       Impact factor: 4.563

Review 2.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

3.  The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway.

Authors:  Lukasz Stawski; Grace Marden; Maria Trojanowska
Journal:  J Immunol       Date:  2017-11-15       Impact factor: 5.422

4.  Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia.

Authors:  Steven M Kornblau; Yi Hua Qiu; Nianxiang Zhang; Neera Singh; Stefan Faderl; Alessandra Ferrajoli; Heather York; Amina A Qutub; Kevin R Coombes; Dennis K Watson
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

5.  Global Gene Expression Analysis in PKCα-/- Mouse Skin Reveals Structural Changes in the Dermis and Defective Wound Granulation Tissue.

Authors:  Nichola H Cooper; Jeya P Balachandra; Matthew J Hardman
Journal:  J Invest Dermatol       Date:  2015-09-09       Impact factor: 8.551

6.  Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.

Authors:  Takashi Taniguchi; Yoshihide Asano; Kaname Akamata; Shinji Noda; Takehiro Takahashi; Yohei Ichimura; Tetsuo Toyama; Maria Trojanowska; Shinichi Sato
Journal:  Arthritis Rheumatol       Date:  2015-02       Impact factor: 10.995

Review 7.  Animal models of scleroderma: current state and recent development.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

8.  Fli1 is a negative regulator of estrogen receptor α in dermal fibroblasts.

Authors:  Tomoyasu Hattori; Lukasz Stawski; Sashidhar S Nakerakanti; Maria Trojanowska
Journal:  J Invest Dermatol       Date:  2011-03-31       Impact factor: 8.551

9.  Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability.

Authors:  Kaname Akamata; Yoshihide Asano; Takashi Yamashita; Shinji Noda; Takashi Taniguchi; Takehiro Takahashi; Yohei Ichimura; Tetsuo Toyama; Maria Trojanowska; Shinichi Sato
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

Review 10.  Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.

Authors:  Maria Trojanowska
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.